A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2

被引：19
作者：
Bu, Yanyan [2 ,3 ]
Shi, Tao [1 ]
Meng, Minghui [2 ,3 ]
Kong, Guiping [2 ,3 ]
Tian, Yingpu [2 ,3 ]
Chen, Quancheng [1 ]
Yao, Xinsheng [1 ,4 ]
Feng, Gensheng [2 ,3 ,5 ]
Cheng, Haifeng [1 ]
Lu, Zhongxian [2 ,3 ]
机构：
[1] Xiamen Univ, Nat Prod Res Ctr, Inst Biomed Res, Xiamen 361005, Fujian, Peoples R China
[2] Xiamen Univ, Xiamen City Key Lab Metab Dis, Xiamen 361005, Fujian, Peoples R China
[3] Xiamen Univ, Metab Dis Res Ctr, Inst Biomed Res, Xiamen 361005, Fujian, Peoples R China
[4] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China
[5] Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Shp2; enhancer; Screening system; Diabetes; Oleanolic acid; OLEANOLIC ACID; MEDICINAL FOODSTUFFS; INSULIN-SECRETION; RATS; EXPRESSION; RESISTANCE; INHIBITORS; DELETION; DEATH; MICE;
D O I：
10.1016/j.bmcl.2010.11.049
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Tyrosine phosphatase Src-homology phosphotyrosyl phosphatase 2 (Shp2) was identified as a potential molecular target for therapeutic treatment of diabetes and obesity. However, there is still no systematic research on the enhancers for the Shp2 enzyme. The present study established a novel powerful model for the high-throughput screening of Shp2 enhancers and successfully identified a new specific Shp2 enhancer, oleanolic acid, from Chinese herbs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：874 / 878
页数：5
相关论文
共 33 条
  • [1] Early fetal death associated with compound heterozygosity for Noonan syndrome-causative PTPN11 mutations
    Becker, Kristin
    Hughes, Helen
    Howard, Karol
    Armstrong, Maggie
    Roberts, Devender
    Lazda, Edgar J.
    Short, John P.
    Shaw, Adam
    Patton, Michael A.
    Tartaglia, Marco
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (11) : 1249 - 1252
  • [2] Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor
    Chen, Liwei
    Sung, Shen-Shu
    Yip, M. L. Richard
    Lawrence, Harshani R.
    Ren, Yuan
    Guida, Wayne C.
    Sebti, Said M.
    Lawrence, Nicholas J.
    Wu, Jie
    [J]. MOLECULAR PHARMACOLOGY, 2006, 70 (02) : 562 - 570
  • [3] The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
    Dance, Marie
    Montagner, Alexandra
    Salles, Jean-Pierre
    Yart, Armelle
    Raynal, Patrick
    [J]. CELLULAR SIGNALLING, 2008, 20 (03) : 453 - 459
  • [4] Protein tyrosine phosphatases: mechanisms of catalysis and regulation
    Denu, JM
    Dixon, JE
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (05) : 633 - 641
  • [5] Shp2 is dispensable in the formation and maintenance of the neuromuscular junction
    Dong, Xian-Ping
    Li, Xiao-Ming
    Gao, Tian-Ming
    Zhang, Eric E.
    Feng, Gen-Sheng
    Xiong, Wen C.
    Mei, Lin
    [J]. NEUROSIGNALS, 2006, 15 (02) : 53 - 63
  • [6] Shp2 as a therapeutic target for leptin resistance and obesity
    Feng, GS
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (01) : 135 - 142
  • [7] Feng Ying-lu, 2006, Zhonghua Zhongliu Zazhi, V28, P844
  • [8] Feng Zi-ming, 2005, Yaoxue Xuebao, V40, P150
  • [9] Antidiabetic and Antioxidant Effects of Oleanolic Acid from Ligustrum lucidum Ait in Alloxan-induced Diabetic Rats
    Gao, Dawei
    Li, Qingwang
    Li, Ying
    Liu, Zhihua
    Fan, Yusheng
    Liu, Zhiwei
    Zhao, Hongwei
    Li, Jian
    Han, Zengsheng
    [J]. PHYTOTHERAPY RESEARCH, 2009, 23 (09) : 1257 - 1262
  • [10] Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking
    Hellmuth, Klaus
    Grosskopf, Stefanie
    Lum, Ching Tung
    Wuertele, Martin
    Roeder, Nadine
    von Kries, Jens Peter
    Rosario, Marta
    Rademann, Joerg
    Birchmeier, Walter
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (20) : 7275 - 7280
1234